These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38810)

  • 1. [Differentiating the action of cataleptogenic bodies (author's transl)].
    Menge HG; Brand U
    Arzneimittelforschung; 1978; 28(9):1506-7. PubMed ID: 38810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate actions and catecholamines.
    Iwamoto ET; Way EL
    Adv Biochem Psychopharmacol; 1979; 20():357-407. PubMed ID: 38641
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
    Rao SG; Hrishikeshavan HJ; Guruswami MN
    Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
    Marchese G; Casu G; Casti P; Spada GP; Pani L
    Eur J Pharmacol; 2009 Oct; 620(1-3):36-41. PubMed ID: 19664616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seasonal changes in the behavioral effects of neuroleptics on white rats].
    Otter MIa; Kalda EI; Erik IuP
    Biull Eksp Biol Med; 1986 Nov; 102(11):577-9. PubMed ID: 2877693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homovanilic acid accumulation in the brain of rats as a possible cause of the inhibitory action of psychotropic substances on behavior and motor activity].
    Zharkovskiĭ AM; Allikmets LKh
    Farmakol Toksikol; 1979; 42(5):467-70. PubMed ID: 39774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuroleptic efficiency of some butyrophenone and fluorinated phenothiazine derivatives (author's transl)].
    Bekemeier H; Krause E
    Pharmazie; 1980; 35(10):634-7. PubMed ID: 6109310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities of detecting and differentiating central nervous effects of drugs in animal experiments with special consideration of behavioral-pharmacologic methods].
    Hoffmeister F; Wuttke W
    Arzneimittelforschung; 1975 Jul; 25(7a):1162-78. PubMed ID: 241358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic influences on opioids activity in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1982; 34(1-3):85-92. PubMed ID: 6891961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lithium modifications of the cataleptogenic properties of various neuroleptic drugs in the rat].
    Dessaigne S; Scotto AM; Guigues M
    C R Seances Soc Biol Fil; 1978; 172(6):1173-80. PubMed ID: 40676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the genotype in the cataleptogenic effect of neuroleptics].
    Skrinskaia IuA; Nikulina EM; Popova NK
    Eksp Klin Farmakol; 1992; 55(6):7-9. PubMed ID: 1363957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonuniform effect of cataleptogenic and atypical neuroleptics on the turning reactions induced by stimulation of the putamen and caudate nucleus in cats].
    Anokhov SS; Arushanian EB
    Farmakol Toksikol; 1984; 47(6):16-20. PubMed ID: 6151517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
    Malec D; Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interactions between ampakines and antipsychotic drugs.
    Johnson SA; Luu NT; Herbst TA; Knapp R; Lutz D; Arai A; Rogers GA; Lynch G
    J Pharmacol Exp Ther; 1999 Apr; 289(1):392-7. PubMed ID: 10087029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.